{"disease":{"id":"neurotypical-adults","name":"neurotypical adults"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06365086","title":"Targeting Personalized Brain States Reflecting Strong and Weak Corticospinal Tract Output in Real-time","phase":"NA","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"University of Texas at Austin","has_results":true},{"nct_id":"NCT06957054","title":"Neural Biomarkers in Fragile X Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Connecta Therapeutics, S.L.","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}